These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 325566)

  • 1. Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs.
    Chedid L; Parant M; Parant F; Lefrancher P; Choay J; Lederer E
    Proc Natl Acad Sci U S A; 1977 May; 74(5):2089-93. PubMed ID: 325566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of the neonate's nonspecific immunity to Klebsiella infection by muramyl dipeptide, a synthetic immunoadjuvant.
    Parant M; Parant F; Chedid L
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3395-9. PubMed ID: 356054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo and in vitro stimulation of nonspecific immunity by the beta-D-p-aminophenyl glycoside of N-acetylmuramyl-L-alanyl-D-isoglutamine and an oligomer prepared by cross-linking with glutaraldehyde.
    Parant M; Damais C; Audibert F; Parant F; Chedid L; Sache E; Lefrancier P; Choay J; Lederer E
    J Infect Dis; 1978 Sep; 138(3):378-86. PubMed ID: 100563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Increase in the non-specific resistance to infection in mice after oral administration of 2 synthetic glycopeptides with adjuvant activity].
    Chedid L; Parant M; Parant F
    C R Acad Hebd Seances Acad Sci D; 1977 Jan; 284(5):405-8. PubMed ID: 404070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonspecific enhancement of host defenses against infection: experimental evidence of a new order of efficacy and safety.
    Polk HC; Calhoun JH; Lowrey LD; Blanchard SP; Brewer RJ; Adams ST; Chedid L
    Surgery; 1981 Aug; 90(2):376-80. PubMed ID: 7020139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of nonspecific host resistance to infection induced by muramyldipeptides.
    Matsumoto K; Ogawa H; Nagase O; Kusama T; Azuma I
    Microbiol Immunol; 1981; 25(10):1047-58. PubMed ID: 7031443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity.
    Chedid LA; Parant MA; Audibert FM; Riveau GJ; Parant FJ; Lederer E; Choay JP; Lefrancier PL
    Infect Immun; 1982 Feb; 35(2):417-24. PubMed ID: 7035362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant activity of synthetic N-acetylmuramyl peptides in rats.
    Tanaka A; Saito R; Sugiyama K; Morisaki I; Kotani S
    Infect Immun; 1977 Jan; 15(1):332-4. PubMed ID: 832904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of certain biological activities of muramyl dipeptide derivatives after conjugation to a multi-poly(DL-alanine)--poly(L-lysine) carrier.
    Chedid L; Parant M; Parant F; Audibert F; Lefrancier F; Choay J; Sela M
    Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6557-61. PubMed ID: 293743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of L18-MDP(Ala), a synthetic derivative of muramyl dipeptide, on nonspecific resistance of mice to microbial infections.
    Osada Y; Mitsuyama M; Une T; Matsumoto K; Otani T; Satoh M; Ogawa H; Nomoto K
    Infect Immun; 1982 Jul; 37(1):292-300. PubMed ID: 6809630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonspecific enhancement of resistance to local bacterial infection in starved mice.
    Galland RB; Trachtenberg LS; Rynerson N; Polk HC
    Arch Surg; 1982 Feb; 117(2):161-4. PubMed ID: 7034676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant polyarthritis. V. Induction by N-acetylmuramyl-L-alanyl-D-isoglutamine, the smallest peptide subunit of bacterial peptidoglycan.
    Chang YH; Pearson CM; Chedid L
    J Exp Med; 1981 Apr; 153(4):1021-6. PubMed ID: 6972989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of carbohydrate analogs (positional, configurational, and optical) of n-acetylmuramoyl-L-alanyl-D-isoglutamine, and their immunoadjuvant activities.
    Hasegawa A; Kaneda Y; Goh Y; Nishibori K; Kiso M; Azuma I
    Carbohydr Res; 1981 Aug; 94(2):143-63. PubMed ID: 7273036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher immunoadjuvant activities of N-acetyl-beta-D-glucosaminyl-(1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine in comparison with N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Tsujimoto M; Kinoshita F; Okunaga T; Kotani S; Kusumoto S; Yamamoto K; Shiba T
    Microbiol Immunol; 1979; 23(9):933-6. PubMed ID: 576117
    [No Abstract]   [Full Text] [Related]  

  • 15. Absence of binding of MDP, a synthetic immunoadjuvant, to anti-peptidoglycan antibodies.
    Audibert F; Heymer B; Gros C; Schleifer KH; Seidl PH; Chedid L
    J Immunol; 1978 Oct; 121(4):1219-22. PubMed ID: 701793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant activity of synthetic 6-O-"mycoloyl"-N-acetylmuramyl-L-alanyl-D-isoglutamine and related compounds.
    Azuma I; Sugimura K; Yamawaki M; Uemiya M; Kusumoto S; Okada S; Shiba T; Yamamura Y
    Infect Immun; 1978 Jun; 20(3):600-7. PubMed ID: 97234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids.
    Kotani S; Watanabe Y; Kinoshita F; Shimono T; Morisaki I
    Biken J; 1975 Jun; 18(2):105-11. PubMed ID: 1180867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fate of two 14C labelled muramyl peptides: Ac-Mur-L-Ala-gamma-D-Glu-meso-A2pm and Ac-Mur-L-Ala-gamma-D-Glu-meso-A2pm-D-Ala-D-Ala in mice. Evaluation of their ability to increase non specific resistance to Klebsiella infection.
    Yapo A; Petit JF; Lederer E; Parant M; Parant F; Chedid L
    Int J Immunopharmacol; 1982; 4(3):143-9. PubMed ID: 7049971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoadjuvant activities of synthetic 6-O-acyl-N-acetylmuramyl-L-alanyl-D-isoglutamine with special reference to the effect of its administration with liposomes.
    Kotani S; Kinoshita F; Morisaki I; Shimono T; Okunaga T; Takada H; Tsujimoto M; Watanabe Y; Kato K; Shiba T; Kusumoto S; Okada S
    Biken J; 1977 Dec; 20(3-4):95-103. PubMed ID: 614856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between the immunoadjuvant activities and pyrogenicities of synthetic N-acetylmuramyl-peptides or -amino acids.
    Kotani S; Watanabe Y; Shimono T; Harada K; Shiba T
    Biken J; 1976 Mar; 19(1):9-13. PubMed ID: 779765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.